Custom Immunoassays for Diverse Applications
Meadowhawk employs three essential technology platforms to meet study needs including plate washer/reader, MSD, and flow cytometer. At all points across the drug discovery continuum, fit-for-purpose assays using these technology platforms, ensure we deploy the “right” stage appropriate strategy to support cost-efficient and timely decision making.
In collaboration with our in vivo team, our immunoanalytical experts provide a range of services, from therapeutic focused PK and immunogenicity to PD biomarkers. Assays can range from commercial, off-the-shelf kits requiring minimal developmental effort to custom designed assays to meet study specific requirements. In all cases, Meadowhawk helps clients to develop and apply assays meeting and exceeding scientific requirements while minimizing start and analysis times and costs.
... fit-for-purpose assays using these technology platforms, ensure we deploy the "right" stage appropriate strategy to support cost-efficient and timely decision making.
Talk to a ScientistState-of-the-Art Labs and equipment in Boston and San Francisco with all studies led by a Principal Investigator.
Range of Biomarker Panel Measurements and Drug Modalities including peptides, multi domain fusion proteins, therapeutic proteins, antibodies (monoclonal, bi-specific, tri-specific), ADCs and more.
Ligand Binding Assays using enzyme or electro-chemiluminescence linked immunosorbent assays (ELISA).
Bioanalysis Across All Modalities and Analyses including pharmacokinetics, anti-drug antibody, and biomarkers.
Use MSD Platform for pharmacokinetics (PK), biomarkers, immunogenicity, cell-based assays, as well as bioanalysis of cell and gene therapies.
Utilize Flow Cytometry for Data Collection to understand the PK/PD profile of the therapeutic and receptor interactions and downstream effects of receptor signaling.
Advanced Immunoanalytical Tools
Meadowhawk Biolabs offers a comprehensive range of assays specifically designed for diverse drug modalities, including peptides, complex proteins, antibodies of all specificities, and even Antibody-Drug Conjugates (ADCs).
To gain a deeper understanding of drug-target engagement, we utilize Ligand Binding Assays like ELISA to measure receptor occupancy. We also offer bioanalysis across all modalities, including pharmacokinetics, immunogenicity, and biomarker analysis. For even more advanced analysis, we leverage the MSD platform for a broader range of applications like PK/PD studies, biomarker analysis, and even cell-based assays. Additionally, flow cytometry provides valuable insights into a drug’s mechanism of action by detailing receptor interactions and downstream cellular effects.
Unlock the full potential of your drug candidates and expedite your path to success.
Partner with MeadowhawkFast-Track LBA Assay for Biologic Drug Discovery
Evaluation and advancement of candidate biologic therapeutics can oftentimes be slow due to their complex structures, needs for antibody reagents and time-consuming assays. See how Meadowhawk designed a generic immunoassay to collect high-quality PK data that is faster, cheaper and can measure various biologics in different species.
IA Case Study
Antibody (immunoglobulin)-based biologics are among the most commonly approved biologic drugs. However, their discovery...
Read